BioCatalystWatch
PRTAWorkspace / PRTA / OverviewCompany library
PROTHENA CORP PUBLIC LTD CO logo

PROTHENA CORP PUBLIC LTD CO

PROTHENA CORP PUBLIC LTD CO (PRTA)

Website

Price
Market cap
Next catalystExpected 1H 2027Moponetug — TargetTau-1 · Phase 2 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Moponetug

Tau MTBR (R1–R3) × 3R/4R tau

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Moponetug

Tau MTBR (R1–R3) × 3R/4R tau

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

Aβ plaques

TDP-43 CYTOPE®

Intracellular pTDP-43

PRX123

Aβ N-terminus × Tau MTBR

Partner / License out

Aggregated α-synuclein × α-Synuclein C-terminus

PreINDP1P2P3FilingApproved
Upcoming / outlook

Moponetug

Tau MTBR (R1–R3) × 3R/4R tau

PreINDP1P2P3FilingApproved
Upcoming / outlook

Misfolded TTR

PreINDP1P2P3FilingApproved
Upcoming / outlook

Misfolded TTR

PreINDP1P2P3FilingApproved
Upcoming / outlook

History / paused

Misfolded κ/λ light chain × Pathogenic light-chain amyloid

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PRTA PR & News

PR & News

PRTA SEC archive